Global Soft Capsules Drugs Market Research Report 2023
Soft gel capsules are typically a gelatin-based shell, containing a liquid. They can be used as a dosage form for a variety of medicines, including complementary medicines, such as vitamins. In some cases, these medicines may have directions for use that say that they can or should be chewed.
According to QYResearch’s new survey, global Soft Capsules Drugs market is projected to reach US$ 20520 million in 2029, increasing from US$ 14590 million in 2022, with the CAGR of 5.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Soft Capsules Drugs market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Soft Capsules Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
According to QYResearch’s new survey, global Soft Capsules Drugs market is projected to reach US$ 20520 million in 2029, increasing from US$ 14590 million in 2022, with the CAGR of 5.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Soft Capsules Drugs market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Soft Capsules Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- GSK
- AstraZeneca
- Boehringer Ingelheim
- Vertex
- Roche
- Novartis
- Teva
- Chiesi
- Sumitomo Dainippon
- Merck
- Atrium Innovations
- Abbott
- Blackmores
- The Clorox Company
- Nature Made
- By-health
- A&Z Pharmaceutical
- Liquid Core Drugs
- Semi-solid Core Drugs
- Hospital Pharmacy
- Retail Pharmacy
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Soft Capsules Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Liquid Core Drugs
1.2.3 Semi-solid Core Drugs
1.3 Market by Application
1.3.1 Global Soft Capsules Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Soft Capsules Drugs Market Perspective (2018-2029)
2.2 Soft Capsules Drugs Growth Trends by Region
2.2.1 Global Soft Capsules Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Soft Capsules Drugs Historic Market Size by Region (2018-2023)
2.2.3 Soft Capsules Drugs Forecasted Market Size by Region (2024-2029)
2.3 Soft Capsules Drugs Market Dynamics
2.3.1 Soft Capsules Drugs Industry Trends
2.3.2 Soft Capsules Drugs Market Drivers
2.3.3 Soft Capsules Drugs Market Challenges
2.3.4 Soft Capsules Drugs Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Soft Capsules Drugs Players by Revenue
3.1.1 Global Top Soft Capsules Drugs Players by Revenue (2018-2023)
3.1.2 Global Soft Capsules Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Soft Capsules Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Soft Capsules Drugs Revenue
3.4 Global Soft Capsules Drugs Market Concentration Ratio
3.4.1 Global Soft Capsules Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Soft Capsules Drugs Revenue in 2022
3.5 Soft Capsules Drugs Key Players Head office and Area Served
3.6 Key Players Soft Capsules Drugs Product Solution and Service
3.7 Date of Enter into Soft Capsules Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 SOFT CAPSULES DRUGS BREAKDOWN DATA BY TYPE
4.1 Global Soft Capsules Drugs Historic Market Size by Type (2018-2023)
4.2 Global Soft Capsules Drugs Forecasted Market Size by Type (2024-2029)
5 SOFT CAPSULES DRUGS BREAKDOWN DATA BY APPLICATION
5.1 Global Soft Capsules Drugs Historic Market Size by Application (2018-2023)
5.2 Global Soft Capsules Drugs Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Soft Capsules Drugs Market Size (2018-2029)
6.2 North America Soft Capsules Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Soft Capsules Drugs Market Size by Country (2018-2023)
6.4 North America Soft Capsules Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Soft Capsules Drugs Market Size (2018-2029)
7.2 Europe Soft Capsules Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Soft Capsules Drugs Market Size by Country (2018-2023)
7.4 Europe Soft Capsules Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Soft Capsules Drugs Market Size (2018-2029)
8.2 Asia-Pacific Soft Capsules Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Soft Capsules Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Soft Capsules Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Soft Capsules Drugs Market Size (2018-2029)
9.2 Latin America Soft Capsules Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Soft Capsules Drugs Market Size by Country (2018-2023)
9.4 Latin America Soft Capsules Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Soft Capsules Drugs Market Size (2018-2029)
10.2 Middle East & Africa Soft Capsules Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Soft Capsules Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Soft Capsules Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Soft Capsules Drugs Introduction
11.1.4 GSK Revenue in Soft Capsules Drugs Business (2018-2023)
11.1.5 GSK Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Soft Capsules Drugs Introduction
11.2.4 AstraZeneca Revenue in Soft Capsules Drugs Business (2018-2023)
11.2.5 AstraZeneca Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Soft Capsules Drugs Introduction
11.3.4 Boehringer Ingelheim Revenue in Soft Capsules Drugs Business (2018-2023)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Vertex
11.4.1 Vertex Company Detail
11.4.2 Vertex Business Overview
11.4.3 Vertex Soft Capsules Drugs Introduction
11.4.4 Vertex Revenue in Soft Capsules Drugs Business (2018-2023)
11.4.5 Vertex Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Soft Capsules Drugs Introduction
11.5.4 Roche Revenue in Soft Capsules Drugs Business (2018-2023)
11.5.5 Roche Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Soft Capsules Drugs Introduction
11.6.4 Novartis Revenue in Soft Capsules Drugs Business (2018-2023)
11.6.5 Novartis Recent Development
11.7 Teva
11.7.1 Teva Company Detail
11.7.2 Teva Business Overview
11.7.3 Teva Soft Capsules Drugs Introduction
11.7.4 Teva Revenue in Soft Capsules Drugs Business (2018-2023)
11.7.5 Teva Recent Development
11.8 Chiesi
11.8.1 Chiesi Company Detail
11.8.2 Chiesi Business Overview
11.8.3 Chiesi Soft Capsules Drugs Introduction
11.8.4 Chiesi Revenue in Soft Capsules Drugs Business (2018-2023)
11.8.5 Chiesi Recent Development
11.9 Sumitomo Dainippon
11.9.1 Sumitomo Dainippon Company Detail
11.9.2 Sumitomo Dainippon Business Overview
11.9.3 Sumitomo Dainippon Soft Capsules Drugs Introduction
11.9.4 Sumitomo Dainippon Revenue in Soft Capsules Drugs Business (2018-2023)
11.9.5 Sumitomo Dainippon Recent Development
11.10 Merck
11.10.1 Merck Company Detail
11.10.2 Merck Business Overview
11.10.3 Merck Soft Capsules Drugs Introduction
11.10.4 Merck Revenue in Soft Capsules Drugs Business (2018-2023)
11.10.5 Merck Recent Development
11.11 Atrium Innovations
11.11.1 Atrium Innovations Company Detail
11.11.2 Atrium Innovations Business Overview
11.11.3 Atrium Innovations Soft Capsules Drugs Introduction
11.11.4 Atrium Innovations Revenue in Soft Capsules Drugs Business (2018-2023)
11.11.5 Atrium Innovations Recent Development
11.12 Abbott
11.12.1 Abbott Company Detail
11.12.2 Abbott Business Overview
11.12.3 Abbott Soft Capsules Drugs Introduction
11.12.4 Abbott Revenue in Soft Capsules Drugs Business (2018-2023)
11.12.5 Abbott Recent Development
11.13 Blackmores
11.13.1 Blackmores Company Detail
11.13.2 Blackmores Business Overview
11.13.3 Blackmores Soft Capsules Drugs Introduction
11.13.4 Blackmores Revenue in Soft Capsules Drugs Business (2018-2023)
11.13.5 Blackmores Recent Development
11.14 The Clorox Company
11.14.1 The Clorox Company Company Detail
11.14.2 The Clorox Company Business Overview
11.14.3 The Clorox Company Soft Capsules Drugs Introduction
11.14.4 The Clorox Company Revenue in Soft Capsules Drugs Business (2018-2023)
11.14.5 The Clorox Company Recent Development
11.15 Nature Made
11.15.1 Nature Made Company Detail
11.15.2 Nature Made Business Overview
11.15.3 Nature Made Soft Capsules Drugs Introduction
11.15.4 Nature Made Revenue in Soft Capsules Drugs Business (2018-2023)
11.15.5 Nature Made Recent Development
11.16 By-health
11.16.1 By-health Company Detail
11.16.2 By-health Business Overview
11.16.3 By-health Soft Capsules Drugs Introduction
11.16.4 By-health Revenue in Soft Capsules Drugs Business (2018-2023)
11.16.5 By-health Recent Development
11.17 A&Z Pharmaceutical
11.17.1 A&Z Pharmaceutical Company Detail
11.17.2 A&Z Pharmaceutical Business Overview
11.17.3 A&Z Pharmaceutical Soft Capsules Drugs Introduction
11.17.4 A&Z Pharmaceutical Revenue in Soft Capsules Drugs Business (2018-2023)
11.17.5 A&Z Pharmaceutical Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Soft Capsules Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Liquid Core Drugs
1.2.3 Semi-solid Core Drugs
1.3 Market by Application
1.3.1 Global Soft Capsules Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Soft Capsules Drugs Market Perspective (2018-2029)
2.2 Soft Capsules Drugs Growth Trends by Region
2.2.1 Global Soft Capsules Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Soft Capsules Drugs Historic Market Size by Region (2018-2023)
2.2.3 Soft Capsules Drugs Forecasted Market Size by Region (2024-2029)
2.3 Soft Capsules Drugs Market Dynamics
2.3.1 Soft Capsules Drugs Industry Trends
2.3.2 Soft Capsules Drugs Market Drivers
2.3.3 Soft Capsules Drugs Market Challenges
2.3.4 Soft Capsules Drugs Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Soft Capsules Drugs Players by Revenue
3.1.1 Global Top Soft Capsules Drugs Players by Revenue (2018-2023)
3.1.2 Global Soft Capsules Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Soft Capsules Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Soft Capsules Drugs Revenue
3.4 Global Soft Capsules Drugs Market Concentration Ratio
3.4.1 Global Soft Capsules Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Soft Capsules Drugs Revenue in 2022
3.5 Soft Capsules Drugs Key Players Head office and Area Served
3.6 Key Players Soft Capsules Drugs Product Solution and Service
3.7 Date of Enter into Soft Capsules Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 SOFT CAPSULES DRUGS BREAKDOWN DATA BY TYPE
4.1 Global Soft Capsules Drugs Historic Market Size by Type (2018-2023)
4.2 Global Soft Capsules Drugs Forecasted Market Size by Type (2024-2029)
5 SOFT CAPSULES DRUGS BREAKDOWN DATA BY APPLICATION
5.1 Global Soft Capsules Drugs Historic Market Size by Application (2018-2023)
5.2 Global Soft Capsules Drugs Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Soft Capsules Drugs Market Size (2018-2029)
6.2 North America Soft Capsules Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Soft Capsules Drugs Market Size by Country (2018-2023)
6.4 North America Soft Capsules Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Soft Capsules Drugs Market Size (2018-2029)
7.2 Europe Soft Capsules Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Soft Capsules Drugs Market Size by Country (2018-2023)
7.4 Europe Soft Capsules Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Soft Capsules Drugs Market Size (2018-2029)
8.2 Asia-Pacific Soft Capsules Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Soft Capsules Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Soft Capsules Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Soft Capsules Drugs Market Size (2018-2029)
9.2 Latin America Soft Capsules Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Soft Capsules Drugs Market Size by Country (2018-2023)
9.4 Latin America Soft Capsules Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Soft Capsules Drugs Market Size (2018-2029)
10.2 Middle East & Africa Soft Capsules Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Soft Capsules Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Soft Capsules Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Soft Capsules Drugs Introduction
11.1.4 GSK Revenue in Soft Capsules Drugs Business (2018-2023)
11.1.5 GSK Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Soft Capsules Drugs Introduction
11.2.4 AstraZeneca Revenue in Soft Capsules Drugs Business (2018-2023)
11.2.5 AstraZeneca Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Soft Capsules Drugs Introduction
11.3.4 Boehringer Ingelheim Revenue in Soft Capsules Drugs Business (2018-2023)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Vertex
11.4.1 Vertex Company Detail
11.4.2 Vertex Business Overview
11.4.3 Vertex Soft Capsules Drugs Introduction
11.4.4 Vertex Revenue in Soft Capsules Drugs Business (2018-2023)
11.4.5 Vertex Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Soft Capsules Drugs Introduction
11.5.4 Roche Revenue in Soft Capsules Drugs Business (2018-2023)
11.5.5 Roche Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Soft Capsules Drugs Introduction
11.6.4 Novartis Revenue in Soft Capsules Drugs Business (2018-2023)
11.6.5 Novartis Recent Development
11.7 Teva
11.7.1 Teva Company Detail
11.7.2 Teva Business Overview
11.7.3 Teva Soft Capsules Drugs Introduction
11.7.4 Teva Revenue in Soft Capsules Drugs Business (2018-2023)
11.7.5 Teva Recent Development
11.8 Chiesi
11.8.1 Chiesi Company Detail
11.8.2 Chiesi Business Overview
11.8.3 Chiesi Soft Capsules Drugs Introduction
11.8.4 Chiesi Revenue in Soft Capsules Drugs Business (2018-2023)
11.8.5 Chiesi Recent Development
11.9 Sumitomo Dainippon
11.9.1 Sumitomo Dainippon Company Detail
11.9.2 Sumitomo Dainippon Business Overview
11.9.3 Sumitomo Dainippon Soft Capsules Drugs Introduction
11.9.4 Sumitomo Dainippon Revenue in Soft Capsules Drugs Business (2018-2023)
11.9.5 Sumitomo Dainippon Recent Development
11.10 Merck
11.10.1 Merck Company Detail
11.10.2 Merck Business Overview
11.10.3 Merck Soft Capsules Drugs Introduction
11.10.4 Merck Revenue in Soft Capsules Drugs Business (2018-2023)
11.10.5 Merck Recent Development
11.11 Atrium Innovations
11.11.1 Atrium Innovations Company Detail
11.11.2 Atrium Innovations Business Overview
11.11.3 Atrium Innovations Soft Capsules Drugs Introduction
11.11.4 Atrium Innovations Revenue in Soft Capsules Drugs Business (2018-2023)
11.11.5 Atrium Innovations Recent Development
11.12 Abbott
11.12.1 Abbott Company Detail
11.12.2 Abbott Business Overview
11.12.3 Abbott Soft Capsules Drugs Introduction
11.12.4 Abbott Revenue in Soft Capsules Drugs Business (2018-2023)
11.12.5 Abbott Recent Development
11.13 Blackmores
11.13.1 Blackmores Company Detail
11.13.2 Blackmores Business Overview
11.13.3 Blackmores Soft Capsules Drugs Introduction
11.13.4 Blackmores Revenue in Soft Capsules Drugs Business (2018-2023)
11.13.5 Blackmores Recent Development
11.14 The Clorox Company
11.14.1 The Clorox Company Company Detail
11.14.2 The Clorox Company Business Overview
11.14.3 The Clorox Company Soft Capsules Drugs Introduction
11.14.4 The Clorox Company Revenue in Soft Capsules Drugs Business (2018-2023)
11.14.5 The Clorox Company Recent Development
11.15 Nature Made
11.15.1 Nature Made Company Detail
11.15.2 Nature Made Business Overview
11.15.3 Nature Made Soft Capsules Drugs Introduction
11.15.4 Nature Made Revenue in Soft Capsules Drugs Business (2018-2023)
11.15.5 Nature Made Recent Development
11.16 By-health
11.16.1 By-health Company Detail
11.16.2 By-health Business Overview
11.16.3 By-health Soft Capsules Drugs Introduction
11.16.4 By-health Revenue in Soft Capsules Drugs Business (2018-2023)
11.16.5 By-health Recent Development
11.17 A&Z Pharmaceutical
11.17.1 A&Z Pharmaceutical Company Detail
11.17.2 A&Z Pharmaceutical Business Overview
11.17.3 A&Z Pharmaceutical Soft Capsules Drugs Introduction
11.17.4 A&Z Pharmaceutical Revenue in Soft Capsules Drugs Business (2018-2023)
11.17.5 A&Z Pharmaceutical Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Soft Capsules Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Liquid Core Drugs
Table 3. Key Players of Semi-solid Core Drugs
Table 4. Global Soft Capsules Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Soft Capsules Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Soft Capsules Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Soft Capsules Drugs Market Share by Region (2018-2023)
Table 8. Global Soft Capsules Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Soft Capsules Drugs Market Share by Region (2024-2029)
Table 10. Soft Capsules Drugs Market Trends
Table 11. Soft Capsules Drugs Market Drivers
Table 12. Soft Capsules Drugs Market Challenges
Table 13. Soft Capsules Drugs Market Restraints
Table 14. Global Soft Capsules Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Soft Capsules Drugs Market Share by Players (2018-2023)
Table 16. Global Top Soft Capsules Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soft Capsules Drugs as of 2022)
Table 17. Ranking of Global Top Soft Capsules Drugs Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Soft Capsules Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Soft Capsules Drugs Product Solution and Service
Table 21. Date of Enter into Soft Capsules Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Soft Capsules Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Soft Capsules Drugs Revenue Market Share by Type (2018-2023)
Table 25. Global Soft Capsules Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Soft Capsules Drugs Revenue Market Share by Type (2024-2029)
Table 27. Global Soft Capsules Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Soft Capsules Drugs Revenue Market Share by Application (2018-2023)
Table 29. Global Soft Capsules Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Soft Capsules Drugs Revenue Market Share by Application (2024-2029)
Table 31. North America Soft Capsules Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Soft Capsules Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Soft Capsules Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Soft Capsules Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Soft Capsules Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Soft Capsules Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Soft Capsules Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Soft Capsules Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Soft Capsules Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Soft Capsules Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Soft Capsules Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Soft Capsules Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Soft Capsules Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Soft Capsules Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Soft Capsules Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 46. GSK Company Detail
Table 47. GSK Business Overview
Table 48. GSK Soft Capsules Drugs Product
Table 49. GSK Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 50. GSK Recent Development
Table 51. AstraZeneca Company Detail
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca Soft Capsules Drugs Product
Table 54. AstraZeneca Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 55. AstraZeneca Recent Development
Table 56. Boehringer Ingelheim Company Detail
Table 57. Boehringer Ingelheim Business Overview
Table 58. Boehringer Ingelheim Soft Capsules Drugs Product
Table 59. Boehringer Ingelheim Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 60. Boehringer Ingelheim Recent Development
Table 61. Vertex Company Detail
Table 62. Vertex Business Overview
Table 63. Vertex Soft Capsules Drugs Product
Table 64. Vertex Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 65. Vertex Recent Development
Table 66. Roche Company Detail
Table 67. Roche Business Overview
Table 68. Roche Soft Capsules Drugs Product
Table 69. Roche Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 70. Roche Recent Development
Table 71. Novartis Company Detail
Table 72. Novartis Business Overview
Table 73. Novartis Soft Capsules Drugs Product
Table 74. Novartis Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Teva Company Detail
Table 77. Teva Business Overview
Table 78. Teva Soft Capsules Drugs Product
Table 79. Teva Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 80. Teva Recent Development
Table 81. Chiesi Company Detail
Table 82. Chiesi Business Overview
Table 83. Chiesi Soft Capsules Drugs Product
Table 84. Chiesi Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 85. Chiesi Recent Development
Table 86. Sumitomo Dainippon Company Detail
Table 87. Sumitomo Dainippon Business Overview
Table 88. Sumitomo Dainippon Soft Capsules Drugs Product
Table 89. Sumitomo Dainippon Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 90. Sumitomo Dainippon Recent Development
Table 91. Merck Company Detail
Table 92. Merck Business Overview
Table 93. Merck Soft Capsules Drugs Product
Table 94. Merck Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 95. Merck Recent Development
Table 96. Atrium Innovations Company Detail
Table 97. Atrium Innovations Business Overview
Table 98. Atrium Innovations Soft Capsules Drugs Product
Table 99. Atrium Innovations Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 100. Atrium Innovations Recent Development
Table 101. Abbott Company Detail
Table 102. Abbott Business Overview
Table 103. Abbott Soft Capsules Drugs Product
Table 104. Abbott Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 105. Abbott Recent Development
Table 106. Blackmores Company Detail
Table 107. Blackmores Business Overview
Table 108. Blackmores Soft Capsules Drugs Product
Table 109. Blackmores Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 110. Blackmores Recent Development
Table 111. The Clorox Company Company Detail
Table 112. The Clorox Company Business Overview
Table 113. The Clorox Company Soft Capsules Drugs Product
Table 114. The Clorox Company Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 115. The Clorox Company Recent Development
Table 116. Nature Made Company Detail
Table 117. Nature Made Business Overview
Table 118. Nature Made Soft Capsules Drugs Product
Table 119. Nature Made Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 120. Nature Made Recent Development
Table 121. By-health Company Detail
Table 122. By-health Business Overview
Table 123. By-health Soft Capsules Drugs Product
Table 124. By-health Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 125. By-health Recent Development
Table 126. A&Z Pharmaceutical Company Detail
Table 127. A&Z Pharmaceutical Business Overview
Table 128. A&Z Pharmaceutical Soft Capsules Drugs Product
Table 129. A&Z Pharmaceutical Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 130. A&Z Pharmaceutical Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 1. Global Soft Capsules Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Liquid Core Drugs
Table 3. Key Players of Semi-solid Core Drugs
Table 4. Global Soft Capsules Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Soft Capsules Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Soft Capsules Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Soft Capsules Drugs Market Share by Region (2018-2023)
Table 8. Global Soft Capsules Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Soft Capsules Drugs Market Share by Region (2024-2029)
Table 10. Soft Capsules Drugs Market Trends
Table 11. Soft Capsules Drugs Market Drivers
Table 12. Soft Capsules Drugs Market Challenges
Table 13. Soft Capsules Drugs Market Restraints
Table 14. Global Soft Capsules Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Soft Capsules Drugs Market Share by Players (2018-2023)
Table 16. Global Top Soft Capsules Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soft Capsules Drugs as of 2022)
Table 17. Ranking of Global Top Soft Capsules Drugs Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Soft Capsules Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Soft Capsules Drugs Product Solution and Service
Table 21. Date of Enter into Soft Capsules Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Soft Capsules Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Soft Capsules Drugs Revenue Market Share by Type (2018-2023)
Table 25. Global Soft Capsules Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Soft Capsules Drugs Revenue Market Share by Type (2024-2029)
Table 27. Global Soft Capsules Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Soft Capsules Drugs Revenue Market Share by Application (2018-2023)
Table 29. Global Soft Capsules Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Soft Capsules Drugs Revenue Market Share by Application (2024-2029)
Table 31. North America Soft Capsules Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Soft Capsules Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Soft Capsules Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Soft Capsules Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Soft Capsules Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Soft Capsules Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Soft Capsules Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Soft Capsules Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Soft Capsules Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Soft Capsules Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Soft Capsules Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Soft Capsules Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Soft Capsules Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Soft Capsules Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Soft Capsules Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 46. GSK Company Detail
Table 47. GSK Business Overview
Table 48. GSK Soft Capsules Drugs Product
Table 49. GSK Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 50. GSK Recent Development
Table 51. AstraZeneca Company Detail
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca Soft Capsules Drugs Product
Table 54. AstraZeneca Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 55. AstraZeneca Recent Development
Table 56. Boehringer Ingelheim Company Detail
Table 57. Boehringer Ingelheim Business Overview
Table 58. Boehringer Ingelheim Soft Capsules Drugs Product
Table 59. Boehringer Ingelheim Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 60. Boehringer Ingelheim Recent Development
Table 61. Vertex Company Detail
Table 62. Vertex Business Overview
Table 63. Vertex Soft Capsules Drugs Product
Table 64. Vertex Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 65. Vertex Recent Development
Table 66. Roche Company Detail
Table 67. Roche Business Overview
Table 68. Roche Soft Capsules Drugs Product
Table 69. Roche Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 70. Roche Recent Development
Table 71. Novartis Company Detail
Table 72. Novartis Business Overview
Table 73. Novartis Soft Capsules Drugs Product
Table 74. Novartis Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Teva Company Detail
Table 77. Teva Business Overview
Table 78. Teva Soft Capsules Drugs Product
Table 79. Teva Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 80. Teva Recent Development
Table 81. Chiesi Company Detail
Table 82. Chiesi Business Overview
Table 83. Chiesi Soft Capsules Drugs Product
Table 84. Chiesi Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 85. Chiesi Recent Development
Table 86. Sumitomo Dainippon Company Detail
Table 87. Sumitomo Dainippon Business Overview
Table 88. Sumitomo Dainippon Soft Capsules Drugs Product
Table 89. Sumitomo Dainippon Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 90. Sumitomo Dainippon Recent Development
Table 91. Merck Company Detail
Table 92. Merck Business Overview
Table 93. Merck Soft Capsules Drugs Product
Table 94. Merck Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 95. Merck Recent Development
Table 96. Atrium Innovations Company Detail
Table 97. Atrium Innovations Business Overview
Table 98. Atrium Innovations Soft Capsules Drugs Product
Table 99. Atrium Innovations Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 100. Atrium Innovations Recent Development
Table 101. Abbott Company Detail
Table 102. Abbott Business Overview
Table 103. Abbott Soft Capsules Drugs Product
Table 104. Abbott Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 105. Abbott Recent Development
Table 106. Blackmores Company Detail
Table 107. Blackmores Business Overview
Table 108. Blackmores Soft Capsules Drugs Product
Table 109. Blackmores Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 110. Blackmores Recent Development
Table 111. The Clorox Company Company Detail
Table 112. The Clorox Company Business Overview
Table 113. The Clorox Company Soft Capsules Drugs Product
Table 114. The Clorox Company Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 115. The Clorox Company Recent Development
Table 116. Nature Made Company Detail
Table 117. Nature Made Business Overview
Table 118. Nature Made Soft Capsules Drugs Product
Table 119. Nature Made Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 120. Nature Made Recent Development
Table 121. By-health Company Detail
Table 122. By-health Business Overview
Table 123. By-health Soft Capsules Drugs Product
Table 124. By-health Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 125. By-health Recent Development
Table 126. A&Z Pharmaceutical Company Detail
Table 127. A&Z Pharmaceutical Business Overview
Table 128. A&Z Pharmaceutical Soft Capsules Drugs Product
Table 129. A&Z Pharmaceutical Revenue in Soft Capsules Drugs Business (2018-2023) & (US$ Million)
Table 130. A&Z Pharmaceutical Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Soft Capsules Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Soft Capsules Drugs Market Share by Type: 2022 VS 2029
Figure 3. Liquid Core Drugs Features
Figure 4. Semi-solid Core Drugs Features
Figure 5. Global Soft Capsules Drugs Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Soft Capsules Drugs Market Share by Application: 2022 VS 2029
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Soft Capsules Drugs Report Years Considered
Figure 10. Global Soft Capsules Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Soft Capsules Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Soft Capsules Drugs Market Share by Region: 2022 VS 2029
Figure 13. Global Soft Capsules Drugs Market Share by Players in 2022
Figure 14. Global Top Soft Capsules Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soft Capsules Drugs as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Soft Capsules Drugs Revenue in 2022
Figure 16. North America Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Soft Capsules Drugs Market Share by Country (2018-2029)
Figure 18. United States Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Soft Capsules Drugs Market Share by Country (2018-2029)
Figure 22. Germany Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Soft Capsules Drugs Market Share by Region (2018-2029)
Figure 30. China Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Soft Capsules Drugs Market Share by Country (2018-2029)
Figure 38. Mexico Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Soft Capsules Drugs Market Share by Country (2018-2029)
Figure 42. Turkey Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. GSK Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 45. AstraZeneca Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 46. Boehringer Ingelheim Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 47. Vertex Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 48. Roche Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 49. Novartis Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 50. Teva Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 51. Chiesi Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 52. Sumitomo Dainippon Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 53. Merck Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 54. Atrium Innovations Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 55. Abbott Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 56. Blackmores Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 57. The Clorox Company Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 58. Nature Made Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 59. By-health Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 60. A&Z Pharmaceutical Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Figure 1. Global Soft Capsules Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Soft Capsules Drugs Market Share by Type: 2022 VS 2029
Figure 3. Liquid Core Drugs Features
Figure 4. Semi-solid Core Drugs Features
Figure 5. Global Soft Capsules Drugs Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Soft Capsules Drugs Market Share by Application: 2022 VS 2029
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Soft Capsules Drugs Report Years Considered
Figure 10. Global Soft Capsules Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Soft Capsules Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Soft Capsules Drugs Market Share by Region: 2022 VS 2029
Figure 13. Global Soft Capsules Drugs Market Share by Players in 2022
Figure 14. Global Top Soft Capsules Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soft Capsules Drugs as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Soft Capsules Drugs Revenue in 2022
Figure 16. North America Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Soft Capsules Drugs Market Share by Country (2018-2029)
Figure 18. United States Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Soft Capsules Drugs Market Share by Country (2018-2029)
Figure 22. Germany Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Soft Capsules Drugs Market Share by Region (2018-2029)
Figure 30. China Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Soft Capsules Drugs Market Share by Country (2018-2029)
Figure 38. Mexico Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Soft Capsules Drugs Market Share by Country (2018-2029)
Figure 42. Turkey Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Soft Capsules Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. GSK Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 45. AstraZeneca Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 46. Boehringer Ingelheim Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 47. Vertex Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 48. Roche Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 49. Novartis Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 50. Teva Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 51. Chiesi Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 52. Sumitomo Dainippon Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 53. Merck Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 54. Atrium Innovations Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 55. Abbott Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 56. Blackmores Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 57. The Clorox Company Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 58. Nature Made Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 59. By-health Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 60. A&Z Pharmaceutical Revenue Growth Rate in Soft Capsules Drugs Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
